'Integra': Safe Harbor For Research Tool Patents?

Law360, New York (August 31, 2007, 12:00 AM EDT) -- On July 27, the Federal Circuit in Integra LifeSciences v. Merck KGaA ruled on the Supreme Court’s broad interpretation of the patent infringement exemption set forth in 35 U.S.C. § 271(e)(1), for “uses reasonably related to the development and submission of information” to the Food and Drug Administration (FDA).

The Federal Circuit reversed the district court’s judgment of infringement, finding that all of the uses at issue qualified under the safe harbor provision of 35 U.S.C. § 271(e)(1) because they were “reasonably related to research that,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.